Xyme

Xyme

AI-designed enzymes catalyzing synthetic chemistry

Overview

Company Does Not Provide H1B Sponsorship

Xyme designs AI-generated enzymes, called xymes, that catalyze chemical reactions and expand the toolkit of synthetic chemistry. It combines artificial intelligence, quantum chemistry, and experimental data to create enzymes tailored to drive specific reactions. The product is a designed enzyme, produced in the lab, validated through experiments, and guided by AI-driven predictions of structure and activity to enable catalysis across a wide range of chemical processes. Xyme differentiates itself by integrating AI, quantum chemistry, and real-world experimental validation to design enzymes capable of catalyzing many reactions, positioning two UK locations (Oxford and Manchester) as innovation hubs. The company aims to address large societal challenges by advancing synthetic chemistry, growing its team with AI and biotech experts, and building a scalable platform to design and deploy new enzymes for diverse industries.

About Xyme

Simplify's Rating
Why Xyme is rated
C
Rated C on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Industrial & Manufacturing

AI & Machine Learning

Biotechnology

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

Oxford, United Kingdom

Founded

2024

Get referred to Xyme

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 2026 news shows active scientific output, including XYM-357, a novel lipase.
  • Xyme joined 10 Downing Street and Bank of America events in 2026.
  • Open roles and LinkedIn hiring posts show continued team expansion in Oxford.

What critics are saying

  • Xyme still looks pre-scale; no disclosed financing, revenue, or customer traction.
  • Hiring repeated protein-design roles in Oxford signals build-out risk and runway pressure.
  • Hopkins's February 2024 Exscientia dismissal creates reputational drag for enterprise partnerships.

What makes Xyme unique

  • Andrew Hopkins founded Xyme in late 2024 after Exscientia.
  • Xyme pairs generative AI with experimental science for de novo enzyme design.
  • Its Oxford and Manchester base targets talent from UK biotech and AI hubs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-5%

1 year growth

0%

2 year growth

13%
This Is Oxfordshire
Jun 22nd, 2026
Oxford scientist recognised for AI molecular discovery work.

Oxford scientist recognised for AI molecular discovery work. Ed Pyzer-Knapp, co-founder and chief scientific officer of Oxford-based AI company Xyme (Image: Supplied) A leading scientific mind is being celebrated for his groundbreaking work. Ed Pyzer-Knapp, co-founder and chief scientific officer of Oxford-based AI company Xyme, has been awarded the Royal Society of Chemistry's (RSC) Interdisciplinary Prize. Dr Pyzer-Knapp received the honour for uniting chemistry, physics and AI into a new approach for molecular discovery. He said: "I'm honoured to receive the RSC Interdisciplinary Prize. "The previous recipients are a who's who of interdisciplinary chemistry; it is a privilege to be among them. "The award comes at the right moment. "The work of the last decade is beginning to bear fruit and I know at Xyme, I'm exactly where I need to be to make the most of it." At Xyme, Dr Pyzer-Knapp leads the development of morphogenic AI, a first-of-its-kind AI able to computationally generate purpose-built molecular machines designed to perform specific chemical reactions. Andrew Hopkins, CEO and co-founder of Xyme, praised his colleague for his vision and technical skill. He said: "Ed is one of only a handful of scientists in the world who can move fluently and expertly across quantum physics, chemistry and AI. "That breadth is what makes genuine innovation possible - and this is what teaching AI physics looks like in practice. "Many congratulations to him." The RSC Interdisciplinary Prize has been awarded annually since 1986 to researchers whose work advances knowledge across disciplinary boundaries. Dr Pyzer-Knapp is one of the youngest recipients in the award's history.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Xyme right now.

Find jobs on Simplify and start your career today

We update Xyme's jobs every few hours, so check again soon! Browse all jobs →